Research & Training Funding

The Ontario Institute for Regenerative Medicine (OIRM) and the Centre for Commercialization of Cancer Immunotherapy and Regenerative Medicine (C3i) are on a mission to make it easier for Ontario’s regenerative medicine (RM) sector to thrive. OIRM and C3i are partnering with the BioInnovation Fund, Bloom Burton & Co., Ontario Bioscience Innovation Organization and Versant Ventures to ensure these made-in-Ontario technologies get the strategic support they need to succeed.

Kick-Start will support successful applicants with resources to create an incorporated business, along with market assessments and an IP/commercialization plan. Investment funding of up to $100,000 and expert guidance from partners will help researcher attract early-stage investment and build value for the new company. The program will also link applicants with investors and other private sector expertise needed to attract funding and to develop and market the proposed technology.

Click here to download the Kick Start Innovation Investment Program summary PDF (displayed below).

Click here to download the Kick Start NOI template (Word file).

Apr 22, 2015 Ontario leads race to develop stem cell therapy for spinal cord injuries

Apr 01, 2015 Stepping forward to a cell therapy for diabetes

Feb 19, 2015 OIRM puts initial investment into heart, vision and immunotherapy research

Nov 25, 2014 New Ontario institute to tackle costly diseases of aging

Jan 28, 2015 Program Announcements